When I I said other indications, I guess I was trying to say other patient populations outside of CKD.
Below is a post from Jagan that mentioned "various other patient groups." Could you speak to that issue.
AFFY - ELAN comparison?
by jagan1961 • May 17, 2013 6:16 PM Flag
We all know AFFY do not have a product pipeline (it had OMONTYS for various other patient groups) and has a PERPETUAL ROYALTY agreement on SALES.
khc...I would if I knew anything about it. I have not seen any other reference to that other than what I cited to you in my earlier response. You probably need to check with Jagan on that. SORRY ...
Maybe there was some confusion with another drug and company. I just saw it mentioned and thought it might prove to be a "kicker" later in the game. I'll try to follow up with jagan, but he doesn't seem to be here today.